STM publisher Thieme Publishing Group has announced that 'Pharmaceutical Substances Version 3.4' is now online. Available via Thieme Chemistry, Pharmaceutical Substances is projected as a comprehensive reference guide to every significant pharmaceutical compound and includes syntheses, patents and applications of all FDA approved active pharmaceutical ingredients (APIs).
Sixteen recently approved APIs have been added to the latest version of the information resource. Recent additions include Fingolimod, the first oral drug for Multiple Sclerosis, and the 3rd taxane anticancer drug Cabazitaxel. Along with these additions more than 40 entries have been updated.
Compiled by renowned leaders in the field, in association with InfoChem and FIZ Chemie, this digital version of the information resource is a web-based, easy-to-navigate portal that utilises standard browser technology. This latest upgrade brings the total number of APIs to 2,511 and includes 47 updated syntheses.
Search for more Reference Tools
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
